Some functions of this side are available with javascript only!
Cancer Center Support Grant (CCSG) Programs
Explore the Research Trends
Explore the Research Network
This is a list of the 20 publications most recently added to the Research Profiles database. This shows the publication activity that is ongoing at the institution.The source of publications for this application is Scopus.
1.
A. Bapsi Chakravarthy; Paul J. Catalano; Joshua K. Mondschein; David I. Rosenthal; Daniel G. Haller; Richard Whittington; Francis R. Spitz; Henry Wagner; Elin R. Sigurdson; Loren K. Tschetter; et al.
Phase II trial of paclitaxel/cisplatin followed by surgery and adjuvant radiation therapy and 5-fluorouracil/leucovorin for gastric cancer (ECOG E7296)
2.
A.M. Gonzalez-Angulo; G.R. Blumenschein
Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer
3.
Albert H. Chao; Erich M. Sturgis; Peirong Yu; Roman J. Skoracki; B. Ashleigh Guadagnolo; Matthew M. Hanasono
Reconstructive outcomes in patients with head and neck sarcoma
4.
Ollivier Laccourreye; David Malinvaud; Hatem Alzahrani; Madeleine Ménard; Dominique Garcia; Pierre Bonfils; F. Christopher Holsinger
Conventional transoral surgery for stage I-II squamous cell carcinoma of the tonsillar region
5.
Xiaoxiang Guan; Erich M. Sturgis; Xicheng Song; Zhensheng Liu; Adel K. El-Naggar; Qingyi Wei; Guojun Li
Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx
6.
Subash C. Gupta; Kanokkarn Phromnoi; Bharat B. Aggarwal
Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1
7.
Hong Zhou; Suhendan Ekmekcioglu; John W Marks; Khalid A Mohamedali; Kaushal Asrani; Keeley K Phillips; Sharron A N Brown; Emily Cheng; Michele B Weiss; Walter N Hittelman; et al.
The TWEAK receptor Fn14 is a therapeutic target in melanoma: Immunotoxins targeting Fn14 receptor for malignant melanoma treatment
8.
Canhua Xiao; Alexandra Hanlon; Qiang Zhang; Kian Ang; David I. Rosenthal; P. Felix Nguyen-Tan; Harold Kim; Benjamin Movsas; Deborah Watkins Bruner
Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy
9.
Qingsong Pang; Qingyi Wei; Ting Xu; Xianglin Yuan; Jose Luis Lopez Guerra; Lawrence B. Levy; Zhensheng Liu; Daniel R. Gomez; Yan Zhuang; Li-E. Wang; et al.
Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer
10.
Xiaoxiang Guan; Zhensheng Liu; Luo Wang; Li-E Wang; Erich M. Sturgis; Qingyi Wei
Functional repeats (TGYCC)n in the p53-inducible gene 3 (PIG3) promoter and susceptibility to squamous cell carcinoma of the head and neck
11.
Avi Khafif; Jesus E. Medina; K.Thomas Robbins; Carl E. Silver; Randal S. Weber; Alessandra Rinaldo; Randall P. Owen; Ashok R. Shaha; Alfio Ferlito
Level v in therapeutic neck dissections for papillary thyroid carcinoma
12.
Jane H. Zhou; Ehab Y. Hanna; Dianna Roberts; Randal S. Weber; Diana Bell
ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma
13.
Alda L. Tam; Edward S. Kim; J. Jack Lee; Joe E. Ensor; Marshall E. Hicks; Ximing Tang; George R. Blumenschein; Christine M. Alden; Jeremy J. Erasmus; Anne Tsao; et al.
Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial
14.
Robert L. Witt; Robert L. Ferris; Edmund A. Pribitkin; Steven I. Sherman; David L. Steward; Yuri E. Nikiforov
Diagnosis and management of differentiated thyroid cancer using molecular biology
15.
Diana Bell; Ehab Y. Hanna
Head and neck adenoid cystic carcinoma: What is new in biological markers and treatment?
16.
Ann H. Klopp; Firas Mourtada; Z. Henry Yu; Beth M. Beadle; Mark F. Munsell; Anuja Jhingran; Patricia J. Eifel
Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer
17.
Xiaoxiang Guan; Zhensheng Liu; Hongliang Liu; Hongping Yu; Li-E Wang; Erich M. Sturgis; Guojun Li; Qingyi Wei
A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer
18.
Siegal Sadetzki; Revital Bruchim; Bernice Oberman; Georgina N. Armstrong; Ching C. Lau; Elizabeth B. Claus; Jill S. Barnholtz-Sloan; Dora Il'Yasova; Joellen Schildkraut; Christoffer Johansen; et al.
Description of selected characteristics of familial glioma patients-Results from the Gliogene Consortium
19.
Graham W. Warren; James R. Marshall; K. Michael Cummings; Benjamin Toll; Ellen R. Gritz; Alan Hutson; Seyedeh Dibaj; Roy Herbst; Carolyn Dresler
Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients
20.
Floyd Christopher Holsinger; Sarina Anne Piha-Paul; Filip Janku; David S. Hong; Johnique T. Atkins; Apostolia M. Tsimberidou; Razelle Kurzrock
Biomarker-directed therapy of squamous carcinomas of the head and neck: Targeting PI3K/PTEN/mTOR pathway